Table 1 Patients characteristics
Patient characteristics | group T | groupL | group E | P value |
|---|---|---|---|---|
n = 21 | n = 135 | n = 20 | ||
Age at surgery,yrs | ||||
median(range) | 52(39-70) | 54(32-75) | 55 (41-69) | All p > 0.05 |
BMI,kg/m2 (median,range) | 24.35(16.9-32.51) | 24.22(16.41-50.78) | 25.45(21.19-32.51) | |
<18 ,n(%) | 1(4.76%) | 1(0.74%) | 0(0%) | |
18-25,n(%) | 13(61.9%) | 76(56.3%) | 8(40%) | |
25-30,n(%) | 6(28.57%) | 45(33.33%) | 10(50%) | |
30-35,n(%) | 1(4.76%) | 11(8.15%) | 2(10%) | |
>35,n(%) | 0(0%) | 2(1.48%) | 0(0%) | |
Surgical stage | ||||
IA | 14(66.67%) | 90(66.67%) | 12(60%) | stage I and II vs stage III and IV all p > 0.05 |
IB | 3(14.29%) | 14(10.37%) | 5(25%) | |
II | 2(9.52%) | 10(7.4%) | 1(5%) | |
IIIA | 2(9.52) | 3(2.22%) | 0(0%) | |
IIIB | 0(0%) | 1(0.74%) | 0(0%) | |
IIIC1 | 0(0%) | 11(8.15%) | 1(5%) | |
IIIC2 | 0(0%) | 4(2.96%) | 1(5%) | |
IVA | 0(0%) | 0(0%) | 0(0%) | |
IVB | 0(0%) | (2.96%) | 0(0%) | |
Histologic grade (G) | ||||
G1 | 9(42.86%) | 55(40.74%) | 9(45%) | distribution of tumor grades, All p > 0.05 |
G2 | 9(42.86%) | 44(32.59%) | 6(30%) | |
G3 | 1(4.76%) | 19(9.63%) | 3(15%) | |
UPSC | 0(0%) | 8(5.93%) | 1(5%) | |
CCC | 0(0%) | 7(5.19%) | 0(0%) | histopathological types, p > 0.05 |
MMMT | 0(0%) | 0(0%) | 0(0%) | |
Gx | 2(9.52%) | 0(0%) | 0(0%) | |
Mixed epithelial carcinoma | 0(0%) | 1(0.74%) | 0(0%) | |
Dedifferentiated carcinoma | 0(0%) | 10.74%) | 1(5%) | |